Data / Form D filings / Daktari Diagnostics, Inc.
Daktari Diagnostics, Inc.: Form D filings
Daktari Diagnostics, Inc., a biotechnology company in Cambridge, MA, filed 9 Form D notices with the SEC between 2009 and 2016. The latest, on May 25, 2016, reports $22.5 million sold of a $22.5 million offering to 31 investors.
Find out what Daktari Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 85 BOLTON STREET, Cambridge, MA, 02140
- Phone
- (617) 336-3299
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1470342
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 25, 2016 | Amendment | $22,499,999 | $22,499,999 | $0 | 31 | Mar 2, 2015 | sec.gov |
| Mar 13, 2015 | New notice | $19,499,999 | $15,499,999 | $4,000,000 | 31 | Mar 2, 2015 | sec.gov |
| Apr 7, 2014 | Amendment | $19,999,995 | $19,999,995 | $0 | 27 | Apr 30, 2013 | sec.gov |
| May 13, 2013 | New notice | $7,000,000 | $7,000,000 | $0 | 26 | Apr 30, 2013 | sec.gov |
| Dec 27, 2011 | New notice | $9,999,999 | $4,999,987 | $5,000,012 | 41 | Dec 15, 2011 | sec.gov |
| Aug 16, 2011 | New notice | $1,250,000 | $1,178,530 | $71,470 | 30 | Jun 29, 2011 | sec.gov |
| Nov 3, 2010 | New notice | $1,800,000 | $1,800,000 | $0 | 32 | Nov 1, 2010 | sec.gov |
| Jul 2, 2010 | New notice | $820,000 | $820,000 | $0 | 42 | Jul 1, 2010 | sec.gov |
| Aug 26, 2009 | New notice | $2,961,783 | $2,547,254 | $414,529 | 39 | Aug 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Kaspar | Director | |
| Aaron Sandoski | Director | |
| Thierry Bernard | Director | |
| David Rubin | Director | |
| Donald Hawthorne | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of May 23, 2016 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Daktari Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.